Theoretical pathway maps how pesticide-contaminated cannabis could harm fetal brain development
Researchers propose that prenatal exposure to cannabis contaminated with the pesticide chlorpyrifos may compound developmental neurotoxicity through overlapping molecular pathways.
Quick Facts
What This Study Found
The proposed adverse outcome pathway shows that cannabinoids and chlorpyrifos share molecular targets affecting neurodevelopment. Both disrupt endocannabinoid signaling and acetylcholinesterase activity, potentially compounding effects on neuronal migration, synaptogenesis, and brain maturation when exposure occurs simultaneously.
Key Numbers
Several US states are moving toward pesticide regulation in cannabis, but standards vary widely. Chlorpyrifos was selected as a model pesticide due to its documented developmental neurotoxicity.
How They Did This
Theoretical construction of an adverse outcome pathway (AOP) by curating existing literature on the molecular, cellular, and tissue-level events linking prenatal cannabinoid-pesticide co-exposure to developmental neurotoxicity.
Why This Research Matters
Cannabis products can contain pesticide residues, and pregnant women may be unknowingly exposed to both. The emerging legal cannabis market still lacks consistent pesticide testing and standards in many jurisdictions.
The Bigger Picture
This paper highlights an overlooked risk: the conversation about cannabis and pregnancy typically focuses on THC alone, ignoring contaminants that may have their own or additive neurotoxic effects.
What This Study Doesn't Tell Us
Entirely theoretical. The proposed adverse outcome pathway has not been experimentally validated as a whole. Real-world pesticide contamination levels on cannabis products are not well characterized.
Questions This Raises
- ?What pesticide residue levels are actually found on commercial cannabis products?
- ?Would the combined exposure at realistic doses produce the predicted neurotoxic effects?
Trust & Context
- Key Stat:
- Overlapping molecular pathways
- Evidence Grade:
- Preliminary: theoretical framework without experimental validation.
- Study Age:
- Published in 2019.
- Original Title:
- Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues.
- Published In:
- Reproductive toxicology (Elmsford, N.Y.), 85, 12-18 (2019)
- Authors:
- Leung, Maxwell C K(2), Silva, Marilyn H, Palumbo, Amanda J, Lohstroh, Peter N, Koshlukova, Svetlana E, DuTeaux, Shelley B
- Database ID:
- RTHC-02133
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Are there pesticides on cannabis products?
Some cannabis products contain pesticide residues, and regulation varies widely by jurisdiction. This paper highlights the potential compounded risk when contaminated cannabis is used during pregnancy.
How could pesticides and cannabis both affect fetal development?
Both can disrupt the endocannabinoid system and other signaling pathways critical to brain development, potentially compounding neurotoxic effects.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-02133APA
Leung, Maxwell C K; Silva, Marilyn H; Palumbo, Amanda J; Lohstroh, Peter N; Koshlukova, Svetlana E; DuTeaux, Shelley B. (2019). Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues.. Reproductive toxicology (Elmsford, N.Y.), 85, 12-18. https://doi.org/10.1016/j.reprotox.2019.01.004
MLA
Leung, Maxwell C K, et al. "Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues.." Reproductive toxicology (Elmsford, 2019. https://doi.org/10.1016/j.reprotox.2019.01.004
RethinkTHC
RethinkTHC Research Database. "Adverse outcome pathway of developmental neurotoxicity resul..." RTHC-02133. Retrieved from https://rethinkthc.com/research/leung-2019-adverse-outcome-pathway-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.